Contineum Therapeutics, Inc. CTNM Q2 2025 earnings
Reported August 5, 2025 · Before market open
EPS-$0.62Miss by $0.06
Revenue estimate$7.5M
EPS estimate-$0.56
Next report
Aug 4, 2026 (In 6 days)EPS estimate-$0.46
Versus estimates
Diluted EPS
Ask the moment Contineum Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Contineum Therapeutics, Inc. report Q2 2025 earnings?
- Contineum Therapeutics, Inc. (CTNM) reported Q2 2025 earnings on August 5, 2025 before market open.
- What were Contineum Therapeutics, Inc.'s Q2 2025 revenue and EPS?
- Contineum Therapeutics, Inc. reported eps of $-0.62 for Q2 2025.
- Did Contineum Therapeutics, Inc. beat estimates in Q2 2025?
- EPS missed the consensus estimate of $-0.56 by $0.06.
- How did Contineum Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 59.0% from $-0.39.
- Where can I find Contineum Therapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001437749-25-024852) directly on SEC EDGAR. The filing index links above go to sec.gov.